Devices/Safety Alert·openFDA/device

Sentus ProMRI OTW QP L-85/49 (Biotronik SE & Co. KG) — Injury

MediumPublished Jul 31, 2026· AI-analyzed Aug 11, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

An injury event has been reported involving the Sentus ProMRI OTW QP L-85/49 device manufactured by Biotronik SE & Co. KG. The source identifies this as an injury event but does not provide specific clinical details regarding the nature or severity of the patient harm.

Who it affects

The manufacturer (Biotronik SE & Co. KG), clinical teams utilizing implantable MRI-compatible leads, and regulatory/QA professionals responsible for cardiovascular device compliance.

Why it matters

The report of an injury associated with an implantable lead suggests potential performance or safety issues that require monitoring. While the source provides limited detail on the mechanism of injury, such reports typically necessitate internal investigations to determine if the event was device-related, user-related, or a known procedural complication. This may impact the risk-benefit profile documented in the device's technical file.

Practical takeaway

Review existing risk management files for this specific lead model to ensure injury profiles are within established thresholds. Verify that post-market surveillance systems are capturing and trending similar injury events to determine if additional reporting or corrective actions are necessary. Ensure clinical teams are monitoring patient outcomes for this device class.

FDA source material

Event type: Injury. Device: Sentus ProMRI OTW QP L-85/49 by Biotronik SE & Co. KG.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.